269 related articles for article (PubMed ID: 23318952)
1. Transcription pattern of p53-targeted DNA repair genes in the hypoxia-tolerant subterranean mole rat Spalax.
Shams I; Malik A; Manov I; Joel A; Band M; Avivi A
J Mol Biol; 2013 Apr; 425(7):1111-8. PubMed ID: 23318952
[TBL] [Abstract][Full Text] [Related]
2. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.
Ashur-Fabian O; Avivi A; Trakhtenbrot L; Adamsky K; Cohen M; Kajakaro G; Joel A; Amariglio N; Nevo E; Rechavi G
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12236-41. PubMed ID: 15302922
[TBL] [Abstract][Full Text] [Related]
3. The expression of p53-target genes in the hypoxia-tolerant subterranean mole-rat is hypoxia-dependent and similar to expression patterns in solid tumors.
Band M; Ashur-Fabian O; Avivi A
Cell Cycle; 2010 Aug; 9(16):3347-52. PubMed ID: 20703075
[TBL] [Abstract][Full Text] [Related]
4. P53 in blind subterranean mole rats--loss-of-function versus gain-of-function activities on newly cloned Spalax target genes.
Avivi A; Ashur-Fabian O; Joel A; Trakhtenbrot L; Adamsky K; Goldstein I; Amariglio N; Rechavi G; Nevo E
Oncogene; 2007 Apr; 26(17):2507-12. PubMed ID: 17043642
[TBL] [Abstract][Full Text] [Related]
5. Adaptive patterns in the p53 protein sequence of the hypoxia- and cancer-tolerant blind mole rat Spalax.
Domankevich V; Opatowsky Y; Malik A; Korol AB; Frenkel Z; Manov I; Avivi A; Shams I
BMC Evol Biol; 2016 Sep; 16():177. PubMed ID: 27590526
[TBL] [Abstract][Full Text] [Related]
6. Living with stress: regulation of antioxidant defense genes in the subterranean, hypoxia-tolerant mole rat, Spalax.
Schülke S; Dreidax D; Malik A; Burmester T; Nevo E; Band M; Avivi A; Hankeln T
Gene; 2012 Jun; 500(2):199-206. PubMed ID: 22441129
[TBL] [Abstract][Full Text] [Related]
7. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
[TBL] [Abstract][Full Text] [Related]
8. Resistance to DNA damage and enhanced DNA repair capacity in the hypoxia-tolerant blind mole rat
Domankevich V; Eddini H; Odeh A; Shams I
J Exp Biol; 2018 Apr; 221(Pt 8):. PubMed ID: 29593080
[TBL] [Abstract][Full Text] [Related]
9. The double benefit of Spalax p53: surviving underground hypoxia while defying lung cancer cells in vitro via autophagy and caspase-dependent cell death.
Ellis M; Stern O; Ashur-Fabian O
Oncotarget; 2016 Sep; 7(39):63242-63251. PubMed ID: 27557517
[TBL] [Abstract][Full Text] [Related]
10. The muscle ankyrin repeat proteins are hypoxia-sensitive: in vivo mRNA expression in the hypoxia-tolerant blind subterranean mole rat, Spalax ehrenbergi.
Band M; Joel A; Avivi A
J Mol Evol; 2010 Jan; 70(1):1-12. PubMed ID: 19967343
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax - a liver transcriptomics approach.
Schmidt H; Malik A; Bicker A; Poetzsch G; Avivi A; Shams I; Hankeln T
Sci Rep; 2017 Oct; 7(1):14348. PubMed ID: 29084988
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
[TBL] [Abstract][Full Text] [Related]
13. Differential expression profiling of the blind subterranean mole rat Spalax ehrenbergi superspecies: bioprospecting for hypoxia tolerance.
Avivi A; Brodsky L; Nevo E; Band MR
Physiol Genomics; 2006 Oct; 27(1):54-64. PubMed ID: 16788006
[TBL] [Abstract][Full Text] [Related]
14. p53--a key player in tumoral and evolutionary adaptation: a lesson from the Israeli blind subterranean mole rat.
Avivi A; Ashur-Fabian O; Amariglio N; Nevo E; Rechavi G
Cell Cycle; 2005 Mar; 4(3):368-72. PubMed ID: 15701965
[TBL] [Abstract][Full Text] [Related]
15. Adaptive methylation regulation of p53 pathway in sympatric speciation of blind mole rats, Spalax.
Zhao Y; Tang JW; Yang Z; Cao YB; Ren JL; Ben-Abu Y; Li K; Chen XQ; Du JZ; Nevo E
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2146-51. PubMed ID: 26858405
[TBL] [Abstract][Full Text] [Related]
16. Cloning and in vivo expression of vascular endothelial growth factor receptor 2 (Flk1) in the naturally hypoxia-tolerant subterranean mole rat.
Band M; Shams I; Joel A; Avivi A
FASEB J; 2008 Jan; 22(1):105-12. PubMed ID: 17726089
[TBL] [Abstract][Full Text] [Related]
17. Genome maintenance and bioenergetics of the long-lived hypoxia-tolerant and cancer-resistant blind mole rat, Spalax: a cross-species analysis of brain transcriptome.
Malik A; Domankevich V; Lijuan H; Xiaodong F; Korol A; Avivi A; Shams I
Sci Rep; 2016 Dec; 6():38624. PubMed ID: 27934892
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic stress tolerance of the blind subterranean mole rat: expression of erythropoietin and hypoxia-inducible factor 1 alpha.
Shams I; Avivi A; Nevo E
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9698-703. PubMed ID: 15210955
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis of the spalax hypoxia survival response includes suppression of apoptosis and tight control of angiogenesis.
Malik A; Korol A; Weber M; Hankeln T; Avivi A; Band M
BMC Genomics; 2012 Nov; 13():615. PubMed ID: 23148642
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia associated NMDA receptor 2 subunit composition: developmental comparison between the hypoxia-tolerant subterranean mole-rat, Spalax, and the hypoxia-sensitive rat.
Band M; Malik A; Joel A; Avivi A
J Comp Physiol B; 2012 Oct; 182(7):961-9. PubMed ID: 22576753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
